Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike M Sathekge

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Seminars in Nuclear Medicine|November 7, 2024
Non-FDG hypoxia tracersKgomotso M G Mokoala, Mike M Sathekge
Current Opinion in Pulmonary Medicine|March 12, 2014
Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CTMariza Vorster, Mike M Sathekge, Jamshed Bomanji
Annals of Nuclear Medicine|January 5, 2021
An overview of the developments and potential applications of <sup>68</sup>Ga-labelled PET/CT hypoxia imagingPhilippa L Bresser, Mariza Vorster, Mike M Sathekge
Nuclear Medicine Communications|May 4, 2022
PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept studyPhilippa L Bresser, Mike M Sathekge, Mariza Vorster
Hellenic Journal of Nuclear Medicine|November 20, 2013
A modified technique for efficient radiolabeling of 68Ga-citrate from a SnO2-based 68Ge/68Ga generator for better infection imagingMariza Vorster, Brenda Mokaleng, Mike M Sathekge, et al.
Journal of Medical Radiation Sciences|June 27, 2022
<sup>68</sup> Ga-nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case seriesPhilippa L Bresser, Janet Reed, Mike M Sathekge, et al.
Seminars in Nuclear Medicine|February 18, 2018
Monitoring Response to TherapyMike M Sathekge, Alfred O Ankrah, Ismaheel Lawal, et al.
Annals of Translational Medicine|August 9, 2024
Design of <sup>225</sup>Ac-PSMA for targeted alpha therapy in prostate cancerKalevi Kairemo, Mankgopo Kgatle, Frank Bruchertseifer, et al.
Seminars in Nuclear Medicine|July 26, 2022
Molecular Imaging of TuberculosisIsmaheel O Lawal, Sofiullah Abubakar, Alfred O Ankrah, et al.
Seminars in Nuclear Medicine|September 13, 2025
Radiolabeled Antibody-Drug Conjugates in the Treatment of Solid TumorsIsmaheel O Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Seminars in Nuclear Medicine|November 7, 2024
Non-FDG hypoxia tracersKgomotso M G Mokoala, Mike M Sathekge
Current Opinion in Pulmonary Medicine|March 12, 2014
Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CTMariza Vorster, Mike M Sathekge, Jamshed Bomanji
Annals of Nuclear Medicine|January 5, 2021
An overview of the developments and potential applications of <sup>68</sup>Ga-labelled PET/CT hypoxia imagingPhilippa L Bresser, Mariza Vorster, Mike M Sathekge
Nuclear Medicine Communications|May 4, 2022
PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept studyPhilippa L Bresser, Mike M Sathekge, Mariza Vorster
Hellenic Journal of Nuclear Medicine|November 20, 2013
A modified technique for efficient radiolabeling of 68Ga-citrate from a SnO2-based 68Ge/68Ga generator for better infection imagingMariza Vorster, Brenda Mokaleng, Mike M Sathekge, et al.
Journal of Medical Radiation Sciences|June 27, 2022
<sup>68</sup> Ga-nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case seriesPhilippa L Bresser, Janet Reed, Mike M Sathekge, et al.
Seminars in Nuclear Medicine|February 18, 2018
Monitoring Response to TherapyMike M Sathekge, Alfred O Ankrah, Ismaheel Lawal, et al.
Annals of Translational Medicine|August 9, 2024
Design of <sup>225</sup>Ac-PSMA for targeted alpha therapy in prostate cancerKalevi Kairemo, Mankgopo Kgatle, Frank Bruchertseifer, et al.
Seminars in Nuclear Medicine|July 26, 2022
Molecular Imaging of TuberculosisIsmaheel O Lawal, Sofiullah Abubakar, Alfred O Ankrah, et al.
Seminars in Nuclear Medicine|September 13, 2025
Radiolabeled Antibody-Drug Conjugates in the Treatment of Solid TumorsIsmaheel O Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Pageof 9